Skip to main content

Prevention of postoperative nausea and vomiting after orthognathic surgery: a scoping review

Abstract

Introduction

Postoperative nausea and vomiting (PONV) is one of the most common adverse events following orthognathic surgery. It’s a distressing feeling for patients and continues to be the cause of postoperative complications such as bleeding, delayed healing, and wound infection. This scoping review aims to identify effective PONV prophylaxis strategies during orthognathic surgery that have emerged in the past 15 years.

Methods

We searched Pubmed, Cochrane Controlled Register of Trials, and Embase from 2008 to May 2023. Studies meeting the following criteria were eligible for inclusion: (1) recruited patients undergo any orthognathic surgery; (2) evaluated any pharmacologic or non-pharmacologic method to prevent PONV. Studies meeting the following criteria were excluded: (1) case series, review papers, or retrospective studies; (2) did not report our prespecified outcomes.

Results

Twenty-one studies were included in this review. Pharmacological methods for PONV prevention include ondansetron and dexamethasone (3 studies), peripheral nerve block technique (4 studies), dexmedetomidine (1 study), pregabalin (2 studies), nefopam (2 studies), remifentanil (1 study), propofol (2 studies), and penehyclidine (1 study). Non-pharmacologic methods include capsicum plaster (1 study), throat packs (2 studies) and gastric aspiration (2 studies).

Conclusions

Based on current evidence, we conclude that prophylactic antiemetics like dexamethasone, ondansetron, and penehyclidine are the first defense against PONV. Multimodal analgesia with nerve block techniques and non-opioid analgesics should be considered due to their notable opioid-sparing and PONV preventive effect. For the non-pharmacological methods, throat packs are not recommended for routine use because of their poor effect and serious complications. More prospective RCTs are required to confirm whether gastric aspiration can prevent PONV effectively for patients undergoing orthognathic surgery.

Peer Review reports

Introduction

Postoperative nausea and vomiting (PONV) is one of the most common adverse events following orthognathic surgery. The incidence of PONV is approximately 30% in the general surgical population [1]. In contrast, patients undergoing orthognathic surgeries suffer much higher risks of PONV, 59.4% of them experienced postoperative nausea (PON) and 28.4% experienced postoperative vomiting (POV) [2]. Frequent PONV is a distressing experience even worse than postoperative pain [3]. It can result in prolonged hospital stay and increased risk of postoperative complications such as bleeding, delayed healing, and wound infection [4].

The etiology of PONV after orthognathic surgery is multifactorial, including patient, surgical, and anesthesia factors. Female patients, less than 25 years old, bimaxillary surgery, procedures more than 3 h, and receiving more than 25 ml/kg intravenous fluids have all been implicated as causative factors in PONV [5,6,7]. Although antiemetics such as 5-HT3 receptor antagonists and dexamethasone are routinely used in orthognathic surgery, their effects on PONV prevention are limited [8, 9].

In recent years, several clinical trials have been conducted by anesthesiologists and surgeons to assess the efficacy of different methods to prevent PONV. Nevertheless, the results of these studies on this topic are contradictory, and not all methods worked well. Up to now, no relevant review or guideline has been summarized for PONV prophylaxis following orthognathic surgery. Thus, this scoping review aims to identify effective PONV prophylaxis strategies during orthognathic surgery that have emerged in the past 15 years.

Materials and methods

This scoping review was conducted and reported according to the Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR).

Search strategy

Two authors independently searched Pubmed, Cochrane Controlled Register of Trials, and Embase from 2008 to May 2023. To avoid the omission of relevant studies, we selected the “All Fields” option rather than “Title/Abstract.” The search strategy was constructed using a combination of the following words: (orthognathic surgery OR bimaxillary osteotomy OR jaw surgery OR mandibular osteotomy) AND (nausea OR vomiting OR emesis). There was no language restriction during the electronic searches.

Inclusion and exclusion criteria

Studies meeting the following criteria were eligible for inclusion: (1) recruited patients undergo any orthognathic surgery; (2) evaluated any pharmacologic or non-pharmacologic method to prevent PONV. Studies meeting the following criteria were excluded: (1) case series, review papers, or retrospective studies; (2) did not report our prespecified outcomes.

Data extraction

Data extraction was performed independently by two authors using a prespecified data extraction form designed by PFG. Disagreements between reviewers were resolved by discussion with a third reviewer. The following information was extracted from the eligible articles: primary author, publication year, type of surgery, intervention methods, number of patients, the occurrence of postoperative nausea and/or vomiting and its P value.

Results

Study selection

A flow diagram summarized the detailed steps of our study selection was described in Fig. 1. Our initial search yielded 291 studies from Pubmed, Cochrane Controlled Register of Trials, and Embase. 210 studies remained after adjusting for duplicates. After screening the titles and abstracts, 178 studies were determined to be not relevant to this scoping review. After screening the full text, 11 studies were excluded according to our exclusion criteria. Finally, 21 RCTs were included in this review [9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29].

Fig. 1
figure 1

Flowchart of study selection process

Study characteristics

The characteristics of included studies are presented in Table 1. All of the twenty-one enrolled RCTs were single-center randomized controlled trials published between 2009 and 2023. Pharmacological methods for PONV prevention include ondansetron and dexamethasone (3 studies), peripheral nerve block technique (4 studies), dexmedetomidine (1 study), pregabalin (2 studies), nefopam (2 studies), remifentanil (1 study), propofol (2 studies), and penehyclidine (1 study). Non-pharmacological methods include capsicum plaster (1 study), throat packs (2 studies) and gastric aspiration (2 studies).

Table 1 Characteristics of PONV Prophylaxis Following Orthognathic Studies

Pharmacological methods

Ondansetron and dexamethasone

Three RCTs investigated ondansetron or dexamethasone. Samieirad et al. [9] compared the preventive antiemetic effects of oral ondansetron combined with dexamethasone versus clonidine combined with dexamethasone administered 1 h before surgery. The incidence of PON or POV did not reach statistical difference between the two groups (53.3% vs. 73.3%, P = 0.256; 0% vs. 6.7%, P = 1.00). Gecaj-Gashi et al. [10] reported that dexamethasone administered before induction of anesthesia was more effective in preventing PON and POV than metoclopramide during 6 h postoperative (9.0% vs. 27.2%, P < 0.05; 0% vs. 18.1%, P < 0.05). However, a study by Lin et al. [11] found that a higher dose of dexamethasone (15 mg vs. 5 mg) did not further reduce the incidence of PON (9.7% vs. 8.0%, P = 0.90) or POV (12.9% vs. 16%, P = 0.74).

Peripheral nerve block technique

Four RCTs assessed peripheral nerve block in orthognathic surgery. Both Chatellier et al. [12] and Vetter et al. [13] found that bilateral inferior alveolar nerve block significantly decreased the incidence of PONV during the first 24 h after mandibular osteotomy (6.3% vs. 42.9%, P = 0.031; 15.4% vs. 40%, P = 0.049). For patients undergoing bimaxillary surgery, ultrasound-guided trigeminal nerve block with 0.25% ropivacaine was effective in reducing intraoperative sufentanil and remifentanil consumption and decreasing the incidence of POV (20% vs. 40%, P = 0.028) [14]. A study by Bertuit et al. [15] examined the role of bilateral mandibular block with 0.75% ropivacaine. Their results suggested that bilateral mandibular block effectively decreased morphine consumption but resulted in more incidence of PONV (46.0% vs. 21.1%, P < 0.01).

Dexmedetomidine

One RCT compared dexmedetomidine and placebo in patients undergoing bimaxillary surgery [16]. This study revealed that dexmedetomidine significantly reduced the incidence of PON (3.3% vs. 47.6%, P < 0.001) and postoperative pain scores in the first 24 h after surgery.

Pregabalin

Two RCTs investigated preoperative oral pregabalin for postoperative pain control and PONV risk. During double jaw surgery, Ahiskalioglu et al. [17] concluded that preoperative oral 150 mg pregabalin significantly reduced postoperative opioid consumption as well as pain scores. The incidence of PONV was lower in the pregabalin group (10% vs. 40%, P = 0.028). Similarly, Khajavi et al. [18] determined that perioperative oral 300 mg pregabalin and 0.2 mg clonidine can improve postoperative pain control in the early stages of recovery. The amount of opioids and incidence of PONV were also lower in patients who received pregabalin and clonidine (5.7% vs. 14.7%, P = 0.005).

Nefopam

Two RCTs comparing nefopam to placebo or fentanyl for PONV prophylaxis were identified. Park et al. [19] investigated the analgesic efficacy and side effects of nefopam. They found that nefopam was an effective analgesic in bimaxillary osteotomy but had no statistical influence on PON (15% vs. 33%, P > 0.05) or POV (15% vs. 29%, P > 0.05). Another prospective randomized controlled trial compared 120 mg nefopam with 700 µg fentanyl used in patient-controlled analgesia (PCA) following bimaxillary orthognathic surgery [20]. Similarly, no difference of PONV was observed between nefopam and fentanyl (27.7% vs. 17.1%, P = 0.568).

Remifentanil

One RCT compared the administration of remifentanil and fentanyl in patients undergoing Le Fort I osteotomy [21]. This study revealed that remifentanil and fentanyl resulted in similar incidence of PON (50% vs. 55.6%, P > 0.05) and POV (25% vs. 33.3%, P > 0.05) in postanesthesia care unit (PACU).

Propofol

Two RCTs compared propofol with inhalational anesthetics for PONV prevention in orthognathic surgeries. Tabrizi et al. [22] determined that propofol and isoflurane used for anesthesia maintenance resulted in a similar incidence of PONV after bimaxillary orthognathic surgery (3.1% vs. 16.7%, P > 0.05). Lin et al. [23] designed a prospective study to compare three anesthesia protocols (including propofol alone, sevoflurane switch to propofol, and sevoflurane alone) to compare the incidence of PONV. Patients in the propofol group had the lowest PONV rate, but it did not reach statistical difference (9.5% vs. 14.3% vs. 28.6%, P = 0.343).

Penehyclidine

One RCT with 3 groups compared the administration of penehyclidine (0.5 mg bolus), penehyclidine (0.25 mg bolus plus 0.25 mg in PCA), and placebo in patients undergoing bimaxillary surgery [24]. This study concluded that both single bolus and single bolus plus a continuous infusion of penehyclidine were effective in preventing PONV (40.2% vs. 28.0% vs. 61.0%, P < 0.003).

Non-pharmacological methods

Capsicum plaster

One prospective RCT with 3 groups (Hegu group = capsicum plaster at the Hegu acupoints, sham group = capsicum plaster on the shoulders, and control group) demonstrated that capsicum plaster at the Hegu acupoints decreased PON (10.7% vs. 42.9% vs. 46.4%, P < 0.01), POV (7.1% vs. 39.3% vs. 42.9%, P < 0.01), and opioid requirement after orthognathic surgery [25]. Patients in the Hegu group had significantly lower pain intensity (P < 0.001).

Throat packs

Two RCTs assessed throat packs versus placebo for PONV prophylaxis. A study by Faro et al. [26] concluded that throat packs can not prevent PON (32% vs. 36%, P = 0.765) or POV (24% vs. 24%, P = 1.000) but were resulted in worse sore throat (72% vs. 36%, P = 0.011) and postoperative dysphagia (60% vs. 12%, P < 0.001). Similarly, Powell et al. [27] showed that there was no difference in the incidence of PONV when patients received throat packs (26.7% vs. 26.7%, P = 1.000).

Gastric aspiration

Two RCTs explored the effect of gastric aspiration by a gastric tube before tracheal extubation to decrease PONV. Schmitt et al. [28] evaluated gastric aspiration in orthognathic surgical patients. Their study found no difference in the overall incidence of PONV (33.3% vs. 33.3%, P = 1.000). Another similar study by Oliveira et al. [29] analyzed 83 patients. Nevertheless, their result showed that gastric aspiration can reduce the risk of postoperative vomiting (15.4% vs. 36.4%, P = 0.031).

Discussion

Opioids have been the cornerstone of perioperative analgesia but are also the main factor causing PONV. In recent years, regional anesthesia techniques and various non-opioid analgesic medications have been promoted to decrease opioids consumption and their side effects. In orthognathic surgery, the maxillary and mandibular branches of the trigeminal nerve can be blocked prior to surgery [30]. Peripheral nerve block techniques provide preemptive analgesia and prevent central sensitization, thereby reducing the surgical stress response and alleviating postoperative pain [31].

In this review, most studies revealed significantly lower incidences of PONV when combined nerve block with general anesthesia. However, Bertuit et al. [15] reported conflicting findings. They found bilateral mandibular block was associated with a higher incidence of PONV, although postoperative morphine consumption was reduced. The author explained that the higher incidence of PONV may be due to the higher Apfel score in the block group, which is the most widely used tool for risk stratification of PONV [1].

Non-opioid medications such as dexmedetomidine and pregabalin also have beneficial effect on PONV prevention. Dexmedetomidine is a highly selective α-2 adrenergic receptor agonist and possesses analgesic, anxiolytic, sympatholytic effects. Recent clinical trials revealed that dexmedetomidine can reduce the incidence of PONV after dental rehabilitation and thoracoscopic lung cancer resection [32, 33]. Pregabalin is a structural gama-aminobutyric acid (GABA) analogue that is frequently preferred for neuropathic pain. In recent years, pregabalin has been used for perioperative pain control as it can provide effective opioid-sparing analgesia [34]. In a meta-analysis of the effects of pregabalin on PONV, preoperative pregabalin was associated with a significant reduction in PONV compared to placebo [35].

Capsicum plaster at classical Chinese acupoints is an alternative to acupuncture, which has been reported to be an effective method for reducing postoperative pain and PONV when applied to the acupuncture points [36]. Nefopam is a non-opioid, non-steroidal centrally acting analgesic that has been used as an alternative to opioids to control mild to moderate pain [37]. Nefopam was shown to provide similar postoperative analgesia to ketorolac when used as an adjuvant analgesic with fentanyl-based PCA [38]. However, nefopam itself can induce PONV according to some studies [39, 40]. The emetic effect of nefopam could be the main reason for the poor outcome in this review.

According to the fourth consensus guidelines for the management of PONV, anesthetic risk factors of PONV include volatile anesthetics, nitrous oxide, and opioids [41]. Apfel et al. [42] reported that the use of volatile anaesthetics was the strongest risk factor for PONV, but restricted to the early (0–2 h) not the late (2–24 h) postoperative period. However, for patients undergoing maxillofacial surgery, PONV incidence in postoperative 2–24 h is 2.7 times higher than 0–2 h [43]. This may be the reason why propofol had no significant preventive effect in this review. Also, a study by Ichinohe et al. [44] reported that nitrous oxide did not aggravate postoperative emesis after orthognathic surgery. So we speculate that opioids, not volatile anesthetics or nitrous oxide, are the main factor causing PONV following orthognathic surgery.

In the pathogenesis of PONV, the activation of muscarinic acetylcholine receptor plays an important part [45]. Penehyclidine, a new muscarinic antagonist with high selectivity of the M3 receptor, is widely used as premedication to reduce glandular secretion [46]. Not only in orthognathic surgery but another two studies in thyroidectomy and strabismus surgery found that penehyclidine was helpful in preventing PONV [46, 47]. The major concern of penehyclidine is potential cognitive side effect. A meta-analysis found that penehyclidine was not associated with increased incidence of postoperative delirium when compared with either scopolamine or placebo [48].

Bleeding is the second most serious complications of orthognathic surgery, which mainly occurs during down fraction of the maxilla after Le Fort I osteotomy or during separation of the pterygoid junction [49, 50]. BMI, circulating blood volume, nasal mucosal injury, and operative time were associated with the risk of intraoperative massive bleeding in orthognathic surgery [51]. It is widely believed that swallow surgical fluids, specifically blood, during surgical procedures contribute to PONV [52]. This theory is supported by the high incidence of PONV in patients undergoing tonsillectomy and adenoidectomy [53]. To decrease blood ingestion, two strategies are emerging in recent years. One strategy is putting throat packs in the pharyngeal cavity, and another is using a gastric tube to aspirate stomach contents.

With insufficient evidence, throat packs are frequently used for decades to prevent blood and pieces of bone aspiration. The ongoing debate about throat packs is whether they can provide a physical barrier against blood and irrigation fluids and reduce the incidence of PONV. A study by Powell et al. can address this question [27]. According to their study, no difference was found for the gastric contents aspirated by a gastric tube when throat packs were used during surgery. Several complications related to throat packs are concerned by clinicians in recent years. The use of throat packs can lead to postoperative sore throat and dysphagia [54]. Vural et al. [55] used chlorhexidine/benzydamine to soak throat packs and observed reduced postoperative throat pain. However, the incidence of PONV was not statistical different when compared with saline-soaked throat packs. More seriously, if the throat packs were forgot to be removed before tracheal extubation, it would result in airway obstruction and even death [56].

Oliveira et al. [29] reported the beneficial effect of gastric aspiration to prevent PONV, whereas Schmitt et al. [28] did not. The main limitation of Schmitt’s study is the small number of patients (12 patients in each group) and the standardization of the anesthetic protocol. These factors may cause bias and influence the reliability of the result. Furthermore, a retrospective study of Wang et al. [57] analyzed 772 patients to discuss the relationship between gastric negative pressure suction and the incidence of PONV after orthognathic surgery. Their results revealed that the incidence of PONV was halved when patients received gastric negative pressure suction.

The enhanced recovery after surgery (ERAS) is a pathway designed to improve patient outcomes, minimize postoperative complications, and reduce the length of hospital stay [58]. Two retrospective studies by Brookes et al. [59] and Stratton et al. [60] assessed the impact of ERAS protocols on PONV after orthognathic surgery. These studies mainly combined pharmacologic and non-pharmacologic methods such as prophylactic antiemetics, multimodal analgesia, propofol-based TIVA, gastric aspiration at the end of surgery. Both of them reported that the incidence of PONV was significantly decreased by using ERAS protocols.

Conclusion

Based on current evidence, we conclude that prophylactic antiemetics like dexamethasone, ondansetron, and penehyclidine are the first defense against PONV. Multimodal analgesia with nerve block techniques and non-opioid analgesics should be considered due to their notable opioid-sparing and PONV preventive effect. For the non-pharmacological methods, throat packs are not recommended for routine use because of their poor effect and serious complications. More prospective RCTs are required to confirm whether gastric aspiration can prevent PONV effectively for patients undergoing orthognathic surgery.

Data availability

The datasets used during the current study available from the corresponding author on reasonable request.

Abbreviations

PONV:

Postoperative nausea and vomiting

PON:

Postoperative nausea

POV:

Postoperative vomiting

PRISMA-ScR:

Preferred reporting items for systematic reviews and meta-analyses extension for scoping reviews

PCA:

Patient-controlled analgesia

PACU:

Postanesthesia care unit

GABA:

Gama-aminobutyric acid

ERAS:

Enhanced recovery after surgery

References

  1. Apfel CC, Laara E, Koivuranta M, Greim CA, Roewer N. A simplified risk score for predicting postoperative nausea and vomiting: conclusions from cross-validations between two centers. Anesthesiology. 1999;91:693–700.

    Article  CAS  PubMed  Google Scholar 

  2. Pourtaheri N, Peck CJ, Maniskas S, Park KE, Allam O, Chandler L, Smetona J, Yang J, Wilson A, Dinis J, Lopez J, Steinbacher DM. A comprehensive single-center analysis of postoperative nausea and vomiting following orthognathic surgery. J Craniofac Surg. 2022;33:584–7.

    Article  PubMed  Google Scholar 

  3. Tateosian vs, Champagne K, Gan TJ. What is new in the battle against postoperative nausea and vomiting? Best Pract Res Clin Anaesthesiol. 2018;32:137–48.

    Article  PubMed  Google Scholar 

  4. Weibel S, Rücker G, Eberhart LH, Pace NL, Hartl HM, Jordan OL, Mayer D, Riemer M, Schaefer MS, Raj D, Backhaus I, Helf A, Schlesinger T, Kienbaum P, Kranke P. Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis. Cochrane Database Syst Rev. 2020;10:CD012859.

    PubMed  Google Scholar 

  5. Phillips C, Brookes CD, Rich J, Arbon J, Turvey TA. Postoperative nausea and vomiting following orthognathic surgery. Int J Oral Maxillofac Surg. 2015;44:745–51.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Ghosh S, Rai KK, Shivakumar HR, Upasi AP, Naik VG, Bharat A. Incidence and risk factors for postoperative nausea and vomiting in orthognathic surgery: a 10-year retrospective study. J Korean Assoc Oral Maxillofac Surg. 2020;46:116–24.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Silva AC, O’Ryan F, Poor DB. Postoperative nausea and vomiting (PONV) after orthognathic surgery: a retrospective study and literature review. J Oral Maxillofac Surg. 2006;64:1385–97.

    Article  PubMed  Google Scholar 

  8. Rodrigo C, Campbell R, Chow J, Tong A. The effect of a 4-mg preoperative intravenous dose of ondansetron in preventing nausea and vomiting after maxillofacial surgery. J Oral Maxillofac Surg. 1996;54:1171–5.

    Article  CAS  PubMed  Google Scholar 

  9. Samieirad S, Sharifian-Attar A, Eshghpour M, Mianbandi V, Shadkam E, Hosseini-Abrishami M, Hashemipour MS. Comparison of Ondansetron versus Clonidine efficacy for prevention of postoperative pain, nausea and vomiting after orthognathic surgeries: a triple blind randomized controlled trial. Med Oral Patol Oral Cir Bucal. 2018;23:e767–76.

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Gecaj-Gashi A, Hasani A, Nikolova Z, et al. Dexamethasone compared with metoclopramide in prevention of postoperative nausea and vomiting in orthognathic surgery. Eur J Anaesthesiol. 2012;29:13.

    Article  Google Scholar 

  11. Lin HH, Kim SG, Kim HY, Niu LS, Lo LJ. Higher dose of Dexamethasone does not further reduce facial swelling after orthognathic surgery: a randomized controlled trial using 3-Dimensional Photogrammetry. Ann Plast Surg. 2017;78:S61–9.

    Article  CAS  PubMed  Google Scholar 

  12. Chatellier A, Dugué AE, Caufourier C, et al. Inferior alveolar nerve block with ropivacaine: effect on nausea and vomiting after mandibular osteotomy. Rev Stomatol Chir Maxillofac. 2012;113:417–22.

    Article  CAS  PubMed  Google Scholar 

  13. Vetter M, Chatellier A, Maltezeanu A, De Mil R, Bénateau H, Veyssière A. The benefit of bilateral inferior alveolar nerve block in managing postoperative nausea and vomiting (PONV) after mandibular osteotomy. J Craniomaxillofac Surg. 2020;48:399–404.

    Article  CAS  PubMed  Google Scholar 

  14. Wang X, Feng Y, Yang X, Li Z, Zhou D. Preoperative ultrasound-guided trigeminal nerve block in orthognathic surgery: a prospective study about its efficacy of Intraoperative Anesthetic Dosage and Postoperative Analgesia. J Oral Maxillofac Surg. 2021;79:2042–50.

    Article  PubMed  Google Scholar 

  15. Bertuit M, Rapido F, Ly H, Vannucci C, Ridolfo J, Molinari N, De Boutray M, Galmiche S, Dadure C, Perrigault PF, Capdevila X, Chanques G. Bilateral mandibular block improves pain relief and morphine consumption in mandibular osteotomies: a prospective, randomized, double-blind, placebo-controlled clinical trial. Reg Anesth Pain Med. 2021;46:322–7.

    Article  PubMed  Google Scholar 

  16. Labafchi A, Shooshtari Z, Grillo R, Sharifian Attar A, Eshghpour M, Samieirad S. The Beneficial Effect of Preoperative Dexmedetomidine in Controlling Postoperative Pain, nausea, and vomiting after orthognathic surgery: a triple-blind Randomized Clinical Trial. J Oral Maxillofac Surg. 2023;81:941–9.

    Article  PubMed  Google Scholar 

  17. Ahiskalioglu A, İnce İ, Aksoy M, Yalcin E, Ahiskalioglu EO, Kilinc A. Effects of a single-dose of pre-emptive Pregabalin on Postoperative Pain and Opioid Consumption after double-Jaw surgery: a Randomized Controlled Trial. J Oral Maxillofac Surg. 2016;74:53.

    Article  Google Scholar 

  18. Khajavi MR, Bahari S, Moharari RS, Pourfakhr P, Etezadi F, Imani F. The clinical effect of oral Gabapentin/Clonidine premedication on postoperative outcomes in patients undergoing orthognathic surgery. Arch Anesth Crit Care. 2018;4:455–8.

    Google Scholar 

  19. Park HJ, Park JU, Yoo W, Moon YE. Analgesic effects of nefopam in patients undergoing bimaxillary osteotomy: a double-blind, randomized, placebo-controlled study. J Craniomaxillofac Surg. 2016;44:210–4.

    Article  PubMed  Google Scholar 

  20. Choi E, Karm MH, So E, Choi YJ, Park S, Oh Y, Yun HJ, Kim HJ, Seo KS. Effects on postoperative nausea and vomiting of nefopam versus fentanyl following bimaxillary orthognathic surgery: a prospective double-blind randomized controlled trial. J Dent Anesth Pain Med. 2019;19:55–66.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Nooh N, Abdelhalim AA, Abdullah WA, Sheta SA. Effect of remifentanil on the hemodynamic responses and recovery profile of patients undergoing single jaw orthognathic surgery. Int J Oral Maxillofac Surg. 2013;42:988–93.

    Article  CAS  PubMed  Google Scholar 

  22. Tabrizi R, Eftekharian HR, Langner NJ, Ozkan BT. Comparison of the effect of 2 hypotensive anesthetic techniques on early recovery complications after orthognathic surgery. J Craniofac Surg. 2012;23:e203–5.

    Article  PubMed  Google Scholar 

  23. Lin S, Chen C, Yao CF, Chen YA, Chen YR. Comparison of different hypotensive anaesthesia techniques in orthognathic surgery with regard to intraoperative blood loss, quality of the surgical field, and postoperative nausea and vomiting. Int J Oral Maxillofac Surg. 2016;45:1526–30.

    Article  CAS  PubMed  Google Scholar 

  24. Wang LK, Cheng T, Yang XD, Xiong GL, Li N, Wang DX. Penehyclidine for prevention of postoperative nausea and vomiting following bimaxillary orthognathic surgery: a randomized, double-blind, controlled trial. J Anesth. 2022;36:122–36.

    Article  PubMed  Google Scholar 

  25. Kim KS, Kim KN, Hwang KG, Park CJ. Capsicum plaster at the Hegu point reduces postoperative analgesic requirement after orthognathic surgery. Anesth Analg. 2009;108:992–6.

    Article  PubMed  Google Scholar 

  26. Faro TF, de Oliveira E, Silva ED, Campos GJ, Duarte NM, Caetano AMM, Laureano Filho JR. Effects of throat packs during orthognathic surgery: a double-blind randomized controlled clinical trial. Int J Oral Maxillofac Surg. 2021;50:349–55.

    Article  CAS  PubMed  Google Scholar 

  27. Powell K, Amin D, Sesanto R, Bryant A, Kukreja P, Waite P. Do oropharyngeal throat packs prevent fluid ingestion during orthognathic surgery? Int J Oral Maxillofac Surg. 2022;51:366–70.

    Article  CAS  PubMed  Google Scholar 

  28. Schmitt ARM, Ritto FG, de Azevedo JGRL, Medeiros PJD, de Mesquita MCM. Efficacy of gastric aspiration in reducing postoperative nausea and vomiting after orthognathic surgery: a double-blind prospective study. J Oral Maxillofac Surg. 2017;75:701–8.

    Article  PubMed  Google Scholar 

  29. De Oliveira A, Lacerda de Toledo G, Marques de Oliveira Chiavaioli G, Henrique Nogueira Guimarães, de Abreu M, Alves Mesquita R. Bruno Figueiredo Amaral M. Efficacy of gastric aspiration to reduce postoperative vomiting after orthognathic surgery: double-blind randomised clinical trial. Br J Oral Maxillofac Surg. 2022;60:493–498.

  30. Shetty V, BhanuPrakash B, Yadav A, Kishore PN, Menon A. Do regional nerve blocks before bimaxillary surgery reduce postoperative pain? J Oral Maxillofac Surg. 2019;78:724–30.

    Article  PubMed  Google Scholar 

  31. Chen YA, Rivera-Serrano CM, Chen C, Chen YR. Pre-surgical regional blocks in orthognathic surgery: prospective study evaluating their influence on the intraoperative use of anaesthetics and blood pressure control. Int J Oral Maxillofac Surg. 2016;45:783–6.

    Article  CAS  PubMed  Google Scholar 

  32. Shama AAA, Elsayed AA, Albraithen AA, Arafa SK. Effect of Dexmedetomidine, Dexamethasone, and Ondansetron on postoperative nausea and vomiting in children undergoing Dental Rehabilitation: a Randomized Controlled Trial. Pain Physician. 2023;26:1–11.

    PubMed  Google Scholar 

  33. Zhu H, Wang S, Wang R, Li B, Zhang J, Zhang W. Effect of dexmedetomidine on postoperative nausea and vomiting in female patients undergoing radical thoracoscopic lung cancer resection. Front Pharmacol. 2024;15:1353620.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Mohammadi A, Yazdani Y, Nazari H, Choubsaz M, Azizi B, Nazari H, Safari-Faramani R, Amiri SM. The effect of a single 75 mg preoperative dose of Pregabalin on postoperative pain in rhinoplasty: a double-blinded, placebo-controlled randomized clinical trial. J Craniomaxillofac Surg. 2020;48:875–9.

    Article  PubMed  Google Scholar 

  35. Grant MC, Betz M, Hulse M, Zorrilla-Vaca A, Hobson D, Wick E, Wu CL. The Effect of Preoperative Pregabalin on postoperative nausea and vomiting: a Meta-analysis. Anesth Analg. 2016;123:1100–7.

    Article  CAS  PubMed  Google Scholar 

  36. Misra MN, Pullani AJ, Mohamed ZU. Prevention of PONV by acustimulation with capsicum plaster is comparable to ondansetron after middle ear surgery. Can J Anaesth. 2005;52:485–9.

    Article  PubMed  Google Scholar 

  37. Lee S, Lee S, Kim H, Oh C, Park S, Kim Y, Hong B, Yoon S, Noh C, Ko Y. The analgesic efficacy of Nefopam in patient-controlled analgesia after laparoscopic gynecologic surgery: a Randomized, Double-Blind, non-inferiority study. J Clin Med. 2021;10:1043.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Jung KT, So KY, Kim SC, Kim SH. Effect of Nefopam-based patient-controlled analgesia with and without Fentanyl on Postoperative Pain Intensity in patients following laparoscopic cholecystectomy: a prospective, randomized, controlled, double-blind Non-inferiority Trial. Med (Kaunas). 2021;57:316.

    Google Scholar 

  39. Koh HJ, Joo J, Kim YS, Lee YJ, Yoo W, Lee MS, Park HJ. Analgesic effect of low dose Nefopam Hydrochloride after Arthroscopic Rotator Cuff Repair: a Randomized Controlled Trial. J Clin Med. 2019;8(4):553.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Son JS, Doo A, Kwon YJ, Han YJ, Ko S. A comparison between ketorolac and nefopam as adjuvant analgesics for postoperative patient-controlled analgesia: a randomized, double-blind, prospective study. Korean J Anesthesiol. 2017;70:612–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Gan TJ, Belani KG, Bergese S, Chung F, Diemunsch P, Habib AS, Jin Z, Kovac AL, Meyer TA, Urman RD, Apfel CC, Ayad S, Beagley L, Candiotti K, Englesakis M, Hedrick TL, Kranke P, Lee S, Lipman D, Minkowitz HS, Morton J, Philip BK. Fourth Consensus guidelines for the management of postoperative nausea and vomiting. Anesth Analg. 2020;131:411–48.

    Article  PubMed  Google Scholar 

  42. Apfel CC, Kranke P, Katz MH, Goepfert C, Papenfuss T, Rauch S, Heineck R, Greim CA, Roewer N. Volatile anaesthetics may be the main cause of early but not delayed postoperative vomiting: a randomized controlled trial of factorial design. Br J Anaesth. 2002;88:659–68.

    Article  CAS  PubMed  Google Scholar 

  43. Ishikawa E, Iwamoto R, Hojo T, Teshirogi T, Hashimoto K, Shibuya M, Kimura Y, Fujisawa T. Cross-sectional study of PONV risk factors for oral surgery after intubated General Anesthesia with Total Intravenous Anesthesia. Anesth Prog. 2022;69:18–23.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Ichinohe T, Kaneko Y. Nitrous oxide does not aggravate postoperative emesis after orthognathic surgery in female and nonsmoking patients. J Oral Maxillofac Surg. 2007;65:936–9.

    Article  PubMed  Google Scholar 

  45. Janicki PK, Vealey R, Liu J, Escajeda J, Postula M, Welker K. Genome-wide association study using pooled DNA to identify candidate markers mediating susceptibility to postoperative nausea and vomiting. Anesthesiology. 2011;115:54–64.

    Article  PubMed  Google Scholar 

  46. Lu T, Li R, Sun J, Chen J. Evaluation of penehyclidine for prevention of post operative nausea and vomitting in patients undergoing total thyroidectomy under total intravenous anaesthesia with propofol-remifentanil. BMC Anesthesiol. 2022;22:317.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Sun J, Cao X, Lu T, Li N, Min X, Ding Z. Penehyclidine mitigates postoperative nausea and vomiting and intraoperative oculocardiac reflex in patients undergoing strabismus surgery: a prospective, randomized, double-blind comparison. BMC Anesthesiol. 2021;21:49.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Yao YT, Ying H, Fang NX, Zhang YB, Yuan X. Penehyclidine Hydrochloride Premedication is not Associated with increased incidence of post-operative cognitive dysfunction or delirium:a systemic review and Meta-analysis. Chin Med Sci J. 2020;35:121–34.

    Article  CAS  PubMed  Google Scholar 

  49. Kim SG, Park SS. Incidence of complications and problems related to orthognathic surgery. J Oral Maxillofac Surg. 2007;65:2438–44.

    Article  PubMed  Google Scholar 

  50. Aydil BA, Akbaş M, Ayhan M, Atalı O, Can S, Çömlekçioğlu Y. Retrospective examination of complications observed in orthognathic surgical surgery in 85 patients. Ulus Travma Acil Cerrahi Derg. 2022;28:698–702.

    PubMed  PubMed Central  Google Scholar 

  51. Sugahara K, Koyama Y, Koyachi M, Watanabe A, Kasahara K, Takano M, Katakura A. A clinico-statistical study of factors associated with intraoperative bleeding in orthognathic surgery. Maxillofac Plast Reconstr Surg. 2022;44:7.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Athanassoglou V, Patel A, McGuire B, Higgs A, Dover MS, Brennan PA, Banerjee A, Bingham B, Pandit JJ. Systematic review of benefits or harms of routine anaesthetist-inserted throat packs in adults: practice recommendations for inserting and counting throat packs: an evidence-based consensus statement by the Difficult Airway Society (DAS), the British Association of Oral and maxillofacial surgery (BAOMS) and the British Association of Otorhinolaryngology, Head and Neck surgery (ENT-UK). Anaesthesia. 2018;73:612–8.

    Article  CAS  PubMed  Google Scholar 

  53. Muhammad R, Wadood F, Haroon T, Khan Z, Shah I. Efficacy of gastric aspiration in reducing post-tonsillectomy vomiting in children. J Ayub Med Coll Abbottabad. 2012;24:28–30.

    PubMed  Google Scholar 

  54. Al-Lami A, Amonoo-Kuofi K, Kulloo P, Lakhani R, Prakash N, Bhat N. A study evaluating the effects of throat packs during nasal surgery: a randomised controlled trial. Eur Arch Otorhinolaryngol. 2017;274:3109–14.

    Article  PubMed  Google Scholar 

  55. Vural Ç, Yurttutan ME, Sancak KT, Tüzüner AM. Effect of chlorhexidine/benzydamine soaked pharyngeal packing on throat pain and postoperative nausea & vomiting in orthognathic surgery. J Craniomaxillofac Surg. 2019;47:1861–7.

    Article  PubMed  Google Scholar 

  56. Basha SI, McCoy E, Ullah R, Kinsella JB. The efficacy of pharyngeal packing during routine nasal surgery–a prospective randomised controlled study. Anaesthesia. 2006;61:1161–5.

    Article  CAS  PubMed  Google Scholar 

  57. Wang J, Zhang Z. Gastric negative pressure suction method reduces the incidence of PONV after orthognathic surgery. Front Surg. 2022;9:882726.

    Article  PubMed  PubMed Central  Google Scholar 

  58. Ljungqvist O, Scott M, Fearon KC. Enhanced recovery after surgery: a review. JAMA Surg. 2017;152:292–8.

    Article  PubMed  Google Scholar 

  59. Brookes CD, Berry J, Rich J, Golden BA, Turvey TA, Blakey G 3rd, Kopp V, Phillips C, Anderson J. Multimodal protocol reduces postoperative nausea and vomiting in patients undergoing Le Fort I osteotomy. J Oral Maxillofac Surg. 2015;73:324–32.

    Article  PubMed  Google Scholar 

  60. Stratton M, Waite PD, Powell KK, Scopel MM, Kukreja P. Benefits of the enhanced recovery after surgery pathway for orthognathic surgery. Int J Oral Maxillofac Surg. 2022;51:214–8.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

This study was supported by Research and Develop Program, West China Hospital of Stomatology, Sichuan University, Chengdu, China (grant number LCYJ-2023-YF-2).

Author information

Authors and Affiliations

Authors

Contributions

PFG and YJ conceived the study and designed the protocol. LZ and SYL identified studies included in the scoping review. YL, MKC and JF collected and interpreted the data. PFG wrote the first draft. All authors reviewed the manuscript.

Corresponding author

Correspondence to Yang Ji.

Ethics declarations

Ethics approval and consent to participate

Not required.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gao, Pf., Zhao, L., Li, Sy. et al. Prevention of postoperative nausea and vomiting after orthognathic surgery: a scoping review. BMC Anesthesiol 24, 121 (2024). https://doi.org/10.1186/s12871-024-02510-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12871-024-02510-z

Keywords